Another piece falling in to place.
Amazing animal studies, IP sewn up. 11 mil in bank.
Pre-clinical in Q3 last step before the Phase 1 which will capture an efficacy signal.
Can't pre-empt results but with a market cap of 25 mil, surely it can do many multiples if the gear works.
Over the next 2 quarters, seems like a great opportunity to buy more tickets to the show.
Ann: European Patent to be Granted for Cholesterol-Lowering Drug, page-4
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
-0.002(3.39%) |
Mkt cap ! $10.38M | |||
| Open | High | Low | Value | Volume |
| 6.3¢ | 6.3¢ | 5.7¢ | $35.22K | 592.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 151330 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.1¢ | 163950 | 1 |
View Market Depth
| Last trade - 15.59pm 21/06/2024 (20 minute delay) ? |
| NYR (ASX) Chart |